These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 25356686)
1. Formulation of the microbicide INP0341 for in vivo protection against a vaginal challenge by Chlamydia trachomatis. Pedersen C; Slepenkin A; Andersson SB; Fagerberg JH; Bergström CA; Peterson EM PLoS One; 2014; 9(10):e110918. PubMed ID: 25356686 [TBL] [Abstract][Full Text] [Related]
2. Protection of mice from a Chlamydia trachomatis vaginal infection using a Salicylidene acylhydrazide, a potential microbicide. Slepenkin A; Chu H; Elofsson M; Keyser P; Peterson EM J Infect Dis; 2011 Nov; 204(9):1313-20. PubMed ID: 21933873 [TBL] [Abstract][Full Text] [Related]
3. Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae. Chu H; Slepenkin A; Elofsson M; Keyser P; de la Maza LM; Peterson EM Int J Antimicrob Agents; 2010 Aug; 36(2):145-50. PubMed ID: 20605703 [TBL] [Abstract][Full Text] [Related]
5. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1. Grammen C; Ariën KK; Venkatraj M; Joossens J; Van der Veken P; Heeres J; Lewi PJ; Haenen S; Augustyns K; Vanham G; Augustijns P; Brouwers J Antiviral Res; 2014 Jan; 101():113-21. PubMed ID: 24269474 [TBL] [Abstract][Full Text] [Related]
6. Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model. Patton DL; Cosgrove Sweeney YT; McCarthy TD; Hillier SL Antimicrob Agents Chemother; 2006 May; 50(5):1696-700. PubMed ID: 16641437 [TBL] [Abstract][Full Text] [Related]
7. Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection. Shankar GN; Alt C J Antimicrob Chemother; 2014 Dec; 69(12):3282-93. PubMed ID: 25139839 [TBL] [Abstract][Full Text] [Related]
11. Erosion of microbicide formulation coating layers: effects of contact and shearing with vaginal fluid or semen. Geonnotti AR; Peters JJ; Katz DF J Pharm Sci; 2005 Aug; 94(8):1705-12. PubMed ID: 15986472 [TBL] [Abstract][Full Text] [Related]
12. Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models. Zeitlin L; Hoen TE; Achilles SL; Hegarty TA; Jerse AE; Kreider JW; Olmsted SS; Whaley KJ; Cone RA; Moench TR Sex Transm Dis; 2001 Jul; 28(7):417-23. PubMed ID: 11460027 [TBL] [Abstract][Full Text] [Related]
13. Poly(sodium 4-styrene sulfonate): evaluation of a topical microbicide gel against herpes simplex virus type 2 and Chlamydia trachomatis infections in mice. Bourne N; Zaneveld LJ; Ward JA; Ireland JP; Stanberry LR Clin Microbiol Infect; 2003 Aug; 9(8):816-22. PubMed ID: 14616702 [TBL] [Abstract][Full Text] [Related]
14. Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal. Karimunnisa S; Atmaram P Drug Dev Ind Pharm; 2013 Sep; 39(9):1328-37. PubMed ID: 22866766 [TBL] [Abstract][Full Text] [Related]
15. Antiviral and immunological effects of tenofovir microbicide in vaginal herpes simplex virus 2 infection. Vibholm L; Reinert LS; Søgaard OS; Paludan SR; Østergaard L; Tolstrup M; Melchjorsen J AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1404-11. PubMed ID: 22867119 [TBL] [Abstract][Full Text] [Related]
16. A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use. Kenney J; Singer R; Derby N; Aravantinou M; Abraham CJ; Menon R; Seidor S; Zhang S; Gettie A; Blanchard J; Piatak M; Lifson JD; Fernández-Romero JA; Zydowsky TM; Robbiani M AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1476-84. PubMed ID: 22737981 [TBL] [Abstract][Full Text] [Related]
17. Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission. Yang J; Li L; Jin H; Tan S; Qiu J; Yang L; Ding Y; Jiang ZH; Jiang S; Liu S AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1498-508. PubMed ID: 22867271 [TBL] [Abstract][Full Text] [Related]
18. Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1. Mahalingam A; Simmons AP; Ugaonkar SR; Watson KM; Dezzutti CS; Rohan LC; Buckheit RW; Kiser PF Antimicrob Agents Chemother; 2011 Apr; 55(4):1650-60. PubMed ID: 21245437 [TBL] [Abstract][Full Text] [Related]
19. Development and characterization of bioadhesive vaginal films of sodium polystyrene sulfonate (PSS), a novel contraceptive antimicrobial agent. Garg S; Vermani K; Garg A; Anderson RA; Rencher WB; Zaneveld LJ Pharm Res; 2005 Apr; 22(4):584-95. PubMed ID: 15846466 [TBL] [Abstract][Full Text] [Related]
20. The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment. Seay K; Khajoueinejad N; Zheng JH; Kiser P; Ochsenbauer C; Kappes JC; Herold B; Goldstein H J Virol; 2015 Sep; 89(18):9559-70. PubMed ID: 26157126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]